Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 9 min ago
Peer-reviewedCC BY 4.0Cells

Mitofusin Activation Delays Aging in Caenorhabditis elegans

  • Jochen Weigele1
  • Lihong Zhang2,3
  • Jiajia Li2
  • Elisabeth Roider4
  • Caroline E. Walton2
  • Gerald W. Dorn1
4 affiliations
  1. 1Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425, USA
  2. 2Department of Internal Medicine, Center for Pharmacogenomics, Washington University in St. Louis, Saint Louis, MO 63110, USA
  3. 3Mitochondria in Motion, Inc., Saint Louis, MO 63110, USA
  4. 4Department of Dermatology, University Hospital of Basel, 4031 Basel, Switzerland
Read full textPDFDOICite

Abstract

Age-linked tissue dysfunction is associated with mitochondrial degeneration manifested as organelle fragmentation and respiratory dysfunction. Efforts to mitigate downstream consequences of mitochondrial degeneration, as with ROS scavengers, have not translated to the human condition. We posit that intrinsic fusion-mediated mechanisms for mitochondrial protection modulate aspects of aging linked to mitochondrial abnormalities. In C. elegans roundworms mitochondrial fusion is mediated by the mitofusin ortholog Fuzzy Onion-1 (fzo-1). Here, the addition of a mitofusin inhibitor, MFI8, to cultures of age-synchronized C. elegans shortened worm lifespan in a concentration-dependent manner. Reciprocally, the mitofusin activators Chimera and 8015-P2 prolonged worm survival in a dose-dependent manner. The pro-survival effect of Chimera was absent in worms lacking its protein target, FZO-1, and at lower concentrations Chimera-amplified survival was further increased by absence of the mitochondrial fission protein that acts in opposition to fzo-1, DRP-1. The mitofusin activator 8015-P2, which is more potent than Chimera, exhibited greater anti-aging effects on lifespan and improved worm healthspan measured as forced swimming activity and resistance to thermal and oxidative stresses. These proof-of-concept worm studies identify aging phenotypes reciprocally related to fzo-1/mitofusin activation status. As 8015-P2 is under development for use in human neurodegenerative diseases, it might alleviate aging phenotypes evoked by mitochondrial degeneration in higher species.

Related

  1. Myricitrin Delays Caenorhabditis elegans Aging: Association with DAF-16, SIR-2.1, and Potential Cholinergic Modulation.
    Lijun Yang, Jiuyi Li, Yihan Zhou +4
    Antioxidants (Basel, Switzerland)Peer-reviewedCC BYFull textCell biologyEurope PMC
  2. An automated genetic screen identifies modulators of stress-induced sleep in Caenorhabditis elegans
    Z. J. Li, H. Honarpisheh, S. Kutagulla +4
    bioRxivPreprintAll rights reservedFull textGenetics & genomicsbioRxiv
  3. Loss of the UFM-1 pathway enhances the ER Unfolded Protein Response under stress to improve proteostasis and organismal health in Caenorhabditis elegans
    Samantha Moores, Betty Ortiz-Gonzalez, Peter Juo
    bioRxivPreprintAll rights reservedFull textCell biologybioRxivPMC
  4. Caenorhabditis elegans DAF-18/PTEN non-autonomously prevents tumors by enhancing calcium sensitivity
    J. Deng, I. C. Djiomo Mbieda, A. M. Chaudhari +5
    bioRxivPreprintAll rights reservedFull textDevelopmental biologybioRxiv
  5. Melatonin regulates LIN-42/PERIOD through its receptor PCDR-1 to promote dark adaptation in Caenorhabditis elegans
    Jia-Hong Duan, Xin-Yue Tang, Yan Du +5
    Communications BiologyPeer-reviewedCC BY 4.0General biologyNatureCrossref

Cite

BibTeXRIS
BibTeX
@article{weigele2026mitofusin,
  title = {{Mitofusin Activation Delays Aging in Caenorhabditis elegans}},
  author = {Jochen Weigele and Lihong Zhang and Jiajia Li and Elisabeth Roider and Caroline E. Walton and Gerald W. Dorn},
  journal = {Cells},
  year = {2026},
  month = sep,
  doi = {10.3390/cells15191789},
  url = {https://www.mdpi.com/2073-4409/15/19/1789},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Mitofusin Activation Delays Aging in Caenorhabditis elegans
AU  - Jochen Weigele
AU  - Lihong Zhang
AU  - Jiajia Li
AU  - Elisabeth Roider
AU  - Caroline E. Walton
AU  - Gerald W. Dorn
PY  - 2026
DA  - 2026/09/30
JO  - Cells
DO  - 10.3390/cells15191789
UR  - https://www.mdpi.com/2073-4409/15/19/1789
AB  - Age-linked tissue dysfunction is associated with mitochondrial degeneration manifested as organelle fragmentation and respiratory dysfunction. Efforts to mitigate downstream consequences of mitochondrial degeneration, as with ROS scavengers, have not translated to the human condition. We posit that intrinsic fusion-mediated mechanisms for mitochondrial protection modulate aspects of aging linked to mitochondrial abnormalities. In C. elegans roundworms mitochondrial fusion is mediated by the mitofusin ortholog Fuzzy Onion-1 (fzo-1). Here, the addition of a mitofusin inhibitor, MFI8, to cultures of age-synchronized C. elegans shortened worm lifespan in a concentration-dependent manner. Reciprocally, the mitofusin activators Chimera and 8015-P2 prolonged worm survival in a dose-dependent manner. The pro-survival effect of Chimera was absent in worms lacking its protein target, FZO-1, and at lower concentrations Chimera-amplified survival was further increased by absence of the mitochondrial fission protein that acts in opposition to fzo-1, DRP-1. The mitofusin activator 8015-P2, which is more potent than Chimera, exhibited greater anti-aging effects on lifespan and improved worm healthspan measured as forced swimming activity and resistance to thermal and oxidative stresses. These proof-of-concept worm studies identify aging phenotypes reciprocally related to fzo-1/mitofusin activation status. As 8015-P2 is under development for use in human neurodegenerative diseases, it might alleviate aging phenotypes evoked by mitochondrial degeneration in higher species.
SN  - 2073-4409
ER  -